Ranibizumab(Lucentis®))

NICE TA 155, TA 274, TA 283 and TA 298

External Links

  • Traffic Light
    Red
  • BNF
    11.8.2
  • Licensed Indicators
    Choroidal neovascularisation, Macular oedema, Macular degeneration
  • Reference
    APC Dec 13
  • Provisional
    No

Do you want to add this to your CPD record?

Did you find this page helpful?